1/32
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Congenital Heart Defect
CHD occurs in 0.8% of live births → Central Septal Defects most common
Multifactorial 70%:
Empiric CHD Recurrence Risk 3-5% - Decreased with maternal folate intake
Genetic 25%:
Chromosomal and Single Gene
Environmental/Teratogenic 5%
Maternal Alcohol, Diabetes, ***PKU***, 1st trimester fever
SSRI → Persistent Pulmonary Hypertension
NSAID → Patent Ductos Arteriosus Closure
Lithium → Epstein’s Anomaly
Noonan Syndrome: Cardinal Features
Overlap with Turners Syndrome → Can rule out Turners if MALE
Generally NORMAL LIFE EXPECTANCY
Cardiac
****Pulmonary Valve Stenosis/Dysplasia*****
Hypertrophic Cardiomyopathy
Dysmorphic features
Down slanting eyes w/ Ptosis
***Webbed Neck**** → TURNER LIKE
***Shield Chest*** → TURNER LIKE
Mild ID → can be normal intelligence
Hematologic:
Easy bruising / Excessive bleeding (epistaxis)
MALES → Cryptorchidism (undescended testicles), bruising fertility, delayed puberty
PRENATAL FINDINGS
Increased Nuchal Translucency
Cystic Hygroma
Noonan Syndrome: Etiology
A RASopathy→ Mutation of RAS/MAPK signaling pathway
PTPN11 50%*** (P.Valve + Short Stature + Bleeding)
SOS1 10-15%
RAF1 5-10% (HCM)
RIT1 5-10% (HCM w/ pre-natal edem/hydrops)
KRAS <5%
NRAS rare
Inheritance
Autosomal Dominant
60% De Novo
40% Inherited
Prenatal Findings (NT or Cystic Hygroma) w/ a NORMAL CHROMSOMAL ANALYSIS → THINK NOONAN SYNDOMRE
CHARGE Syndrome: Clinical Features
Clinical Features is VARIABLE and can be mild to severe and encompass MANY organ systems
Life Expectancy CAN BE DECREASED
Coloboma: piece of iris missing, pupil too big and misshapen
Heart Defects: wide variety (70-80%)
ToF, VSD, ASD, Aortic Arch, PDA,
Atresia of the Choanae: back of nasal passage blocked
Restricted Growth/development:
Genital Abnormalities: (particularly males) hypogonadism, delayed puberty
Ear Abnormalities: Hearing loss (Conductive AND Senso-neural), external ear abnormality
****HEARING LOSS****
POOR BLANCE (hypoplastic or absent semi-circular canals)
Additional features discovered after gene was identified
Brain
Seizures
Abnormalities (Dandy walker, microcephaly,
****Cranial Nerve Abnormalities**** → contributes to hearing loss
Endocrine Dysfunction
CHARGE Syndrome: Etiology
Gene: CHD7 (important for Neural Crest Cell migration)
Inheritance
Autosomal Dominant
90% De Novo
10% Inherited
Can be inherited from a mildy affect parent that didn’t know they had it
Marfan Syndrome: Clinical Features
****Aortic Root Dilation****
May progress to aneurysm, dissection, rupture → LEADING CAUSE OF DEATH
untreated = shortened life expectant
Eye
***Ectopia Lentis*** → UPWARD DISPLACMENT (vs. downward for Homocysturia)
Skeletal
Tall stature
Long, slender fingers
Pectus Excavatum / carinatum***
Scoliosis
Joint hypermobility***
Pulmonary
****Pneumothorax****
Spine
***Dura Ectasia*** (weakening or enlarging of membrane around spinal cord)
Treatment
Echocardiogram 2 times a year
Beta Blockers + Angiotensin receptor blockers (Losartan) decreased progression of Aortic Wall weakening
Marfan Syndrome: Etiology
Gene: FBN1 (important for connective tissue)
Inheritance
Autosomal Dominant
75% Inherited
25 De Novo
****PATERNAL AGE EFFECT****
Marfan-Like Syndrome
Conditions that have Marfanoid features PLUS additional signs:
Loeys-Dietz (TGFBR1 + TGFBR2): Abnormal Palate and DIFFUE aneurysm (throughout the body)
Homocystinuria (CBS): Mental retardation and High Homocysteine blood levels
Beals syndrome (FBN2): contracture and crumpled ears
Multiple Endocrine Neoplasia (MEN) 2A and 2B (RET): Pheocytocytoma and Medullary Thyroid cancer
Ehlers-Danlos Syndromes: Overview
Group of hereditary connective tissue disorder caused by collagen gene mutation and sharing common cardinal features:
Joint hypermobility: joint flexibility, joint dislocation
Skin hyperextensibility and fragility: easy bruising, slow healing
Connective tissue fragility
Hernias
Valvular hear disease
Preterm delivery
Bowel dilation/rupture
3 main types
Hypermobile EDS
Classical EDS
Vascular EDS
Elhers Danlos Syndrome - Hypermobile
Gene: NO SINGLE GENE has been identified DESPITE being the most commo form of EDS (80-90% of EDS cases)
Inheritance
Autosomal dominant
Variable expressivity
Diagnosis is made CLINICALLY
Clinical Features
mostly joint flexibility with MINIMAL SKIN FINDINGS
Normal life expectancy
Musculoskeletal
Joint hypermobility - chronic joint pain, dislocations/subluxation
Flat feet
Skin
NO SEVERE FRAGILITY
mildly stretchy
easy bruising (wound healing not affected)
Other
Chronic fatigue
GI discomfort (IBS)
Autonomic dysfunction (common)
Orthostatic intolerance
Postural orthostatic tach cardia syndrome (POTS)
Elhers Danlos Syndrome - Classical
Gene: COL5A1, COL5A2 (regulates collagen type V)
Inheritance
Autosomal Dominant
Inherited 50%
De Novo 50%
Clinical Features
Skin findings are MUCH more pronounced than hEDS
Life expectancy normal
Musculoskeletal (less severe than hEDS)
Joint hypermobility
recurrent dislocations
Chronic joint pain
Skin (way more pronounced than hEDS)
EXTREMELY stretchy
Fragile
****POOR WOUND HEALING****
****EASY BLEEDING****
****SCARS**** (knees, elbows, forehead, chin)
Cardiac (not as bad as vEDS)
Mild Aortic Root Dilation
Mild mitral valve prolapse
Other
Organ prolapse and hernia
Ehlers Danlos Syndrome - Vascular
Gene: COL3A1 (encodes type III collagen)
Inheritance
Autosomal dominant
Inherited 50%
De Novo 50%
Clinical features
Mostly artery, intestinal and uterine fragility
Life expectancy REDUCED (vascular dissection/rupture)
Vascular
Arterial aneurysm/ dissection/ rupture (spontaneous)
Carotid, Iliac, Mesentric, RENAL, Brain
Aorta (NOT AS MUCH AS MARFANS)****
GI
Spontaneous bowel perforation (rupture
Uterine
Pregnancy risk → uterine rupture
Muscoskeletal
mild hypermobility - FINGERS ONLY
Skin
NOT super stretchy (unlike hEDS and cEDS)
*****thin/ translucent skin*****
Easy bruising
Face
Aged appearance
Thin nose, lips
narrow face
small chin
Management
No contact sports, working out, unnecessary surgery
PREGNACY is HIGH RISK
Familial Hypertrophic Cardiomyopathy: Overview
Genes: MYBPC3 (50%), MYH7(40%)
MYBPC3: later onset, slower progression less severe
MYH7: earlier onset, greater penetrance for young, more severe
Inheritance
Autosomal Dominant
Inherited 90%
De Novo 10%
***AGE DEPENDENT PENETRANCE***
No symptoms as infant + child
Early and Late Adulthood features can emerge
Some carriers NEVER show phenotype
Clinical Features
Left Ventricle Hypertrophy (>15mm wall thickness)
Shortness of breath
Palpitations
Exercise intolerance
Passing out (syncope
SUDDEN CARDIAC DEATH (can be first manifestation)
Left ventricular outflow tract obstruction → HEART MURMUR
Atrial Fibrillation → heart failure and STROKE
Familial Hypertrophic Cardiomyopathy: Recommendations
Diagnosis
Physical exam → heart murmur check
Electrocardiogram
deep Q waves
T-wave inversion
ventricular ectopy
Echocardiogram
Treatments
Beta blockers (1st line) (slow heart rate)
Calcium channel blockers (slow heart rate)
Surgical
Implantable Cardioverter-Defibrillator
Septal myectomy
Alcohol septal ablation
Family Recommendations
even if testing negative, PERDIOIC CLINCIAL SCREENING still recommended since familial cause of HCM remain unidentified
Syndromic HCM
Noonan Syndrome
as well as other RASopathies
Pompe Syndrome
Friedreich’s Ataxia
Fabray Disease
Familial Dilated Cardiomyopathy: Overview
Gene: TTN (30%), *LMNA* (10%), *MYH7* (5-10%) → many other genes
LMNA: electrical disease before pump failure → AV block/Sinus node dysfunction BEFORE left-ventricle dysfunction develops → ****MUCH HIGHER RISK OF SCD than TTN****
Inheritance
Autosomal Dominant
Mostly inherited
LMNA: 10-30% De Novo Rate
***AGE RELATED PENETRANCE***
Incomplete Penetrance
Clinical Features
Dilated Cardiomyopathy
Fatigue
Shortness of breath (ESCPIALLY LYING FLAT)
Exercise intolerance
Palpitations
Passing out (syncope)
Heart Failure (progressive reduction of ejection fraction)
Arrythmias
Atrial + ventricular fibrillation
SUDDEN CARDIAC DEATH
***LMNA ESPECILLAY**
Familial Dilated Cardiomyopathy: Recomendations